Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.85Price to Sales
VS
Market
Sector
Industry
History
$ 14.01Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information
Ticker
PHATCompany Name
PHATHOM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHATHOM PHARMACEUTICALS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PHAT - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 666.87M | 5.85 | $ 114.04M |
| 3/31/2025 | $ 234.58M | 2.87 | $ 81.86M |
| 12/31/2024 | $ 410.86M | 7.44 | $ 55.25M |
| 9/30/2024 | $ 1.26B | 48.15 | $ 26.27M |
| 6/30/2024 | $ 700.23M | 70.6 | $ 9.92M |
| 3/31/2024 | $ 590.62M | 227.69 | $ 2.59M |
| 12/31/2023 | $ 531.56M | 779.41 | $ 682K |
| 9/30/2023 | $ 450M | 0 | $ 0 |
| 6/30/2023 | $ 891.53M | 0 | $ 0 |
| 3/31/2023 | $ 542.12M | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average P/S has been 163.14.
- The median P/S for PHATHOM PHARMACEUTICALS INC during this period was 48.15
- PHATHOM PHARMACEUTICALS INC reached its highest P/S over the past 5 years at 779.41.
- The lowest P/S recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe 2.87
PHATHOM PHARMACEUTICALS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for PHATHOM PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 1.2B ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] PHAT - Price to Sales, Last 5 years
2.87
Minimum
Mar 31, 2025
779.41
Maximum
Dec 31, 2023
163.14
Average
48.15
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |